Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

This study has been terminated.
(The trial was terminated because of deviations from the protocol.)
AESCA Pharma GmbH
Information provided by (Responsible Party):
Indivior Inc. Identifier:
First received: January 17, 2006
Last updated: November 21, 2012
Last verified: February 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)